| | |
| | |
| Clinical data | |
|---|---|
| Other names | 2C-G-0; 2,5-Dimethoxy-3,4-dimethylphenethylamine; 3,4-Dimethyl-2,5-dimethoxyphenethylamine; 3-Methyl-2C-D |
| Routes of administration | Oral [1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Duration of action | 18–30 hours [1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H19NO2 |
| Molar mass | 209.289 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
2C-G, or 2C-G-0, also known as 3,4-dimethyl-2,5-dimethoxyphenethylamine or as 3-methyl-2C-D, is a psychedelic phenethylamine of the 2C family. [1] First synthesized by Alexander Shulgin, it has structural and pharmacodynamic properties similar to 2C-D and Ganesha (G). [1] The drug has a number of known homologues, which are known as the 2C-G series of compounds. [1]
In Alexander Shulgin's book PiHKAL (Phenethylamines I Have Known and Loved), the dose range is listed as 20 to 35 mg orally. [1] Effects are similar to the related Ganesha, and are extremely long lasting; the duration is 18 to 30 hours. [1] Visual effects are muted or absent, and it is described as an "insight-enhancer". [1] Unlike other members of the 2C series, 2C-G is nearly as potent as its amphetamine form. [1]
The chemical synthesis of 2C-G has been described. [1]
Several homologues of 2C-G (2C-G-0) were also synthesized and/or tested by Alexander Shulgin. [1] These include 2C-G-3, 2C-G-5, and 2C-G-N. [1] Some, such as 2C-G-1, 2C-G-2, 2C-G-4, and 2C-G-6, are possible to synthesize in principle but impossible or extraordinarily difficult to do so in practice. [1]
| Compound | Details | Structure |
|---|---|---|
| 2C-G-1 | CAS #: 2888537-47-9 The synthesis of this compound has not been reported, but it is described prophetically in WO2022271982 | |
| 2C-G-2 | CAS #: 2888537-48-0 The synthesis of this compound has not been reported, but it is described prophetically in WO2022271982 | |
| 2C-G-3 | CAS #: 207740-19-0 Dose: 16–25 mg | |
| 2C-G-4 | CAS #: 952006-59-6 Partially synthesized but not tested. | |
| 2C-G-5 | CAS #: 207740-20-3 Dose: 10–16 mg | |
| 2C-G-6 | CAS #: 2888537-49-1 The synthesis of this compound has not been reported, but it is described prophetically in WO2022271982 | |
| 2C-G-N | CAS #: 207740-21-4 Dose: 20–40 mg | |
2C-G was first described in the literature by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). [1]
As of October 31, 2016; 2C-G is a controlled substance (Schedule III) in Canada. [2]
2C-G and all other compounds featuring in PiHKAL are Class A drugs in the United Kingdom.
In the United States 2C-G is considered a Schedule I controlled substance as a positional isomer of 2C-E and DOM. [3]